Amy O'Shaughnessy

Director, Marketing at Bristol Myers Squibb

Amy O'Shaughnessy is a seasoned marketing professional currently serving as the Director of Worldwide Commercial Marketing for Neuroscience at Bristol Myers Squibb (BMS).1 Her career at BMS has been marked by progressive growth and increasing responsibilities in the marketing domain.

Career at Bristol Myers Squibb

Amy has held several key positions at Bristol Myers Squibb:

Director, Worldwide Commercial Marketing, Neuroscience (current role)
Associate Director, Professional Marketing
Associate Director of Digital Marketing
Digital Marketing Specialist

Her tenure at BMS has allowed her to develop expertise in various aspects of pharmaceutical marketing, with a particular focus on digital strategies and professional marketing.

Professional Background

Prior to joining Bristol Myers Squibb, Amy gained valuable experience in the healthcare marketing industry. She has worked with renowned agencies and organizations, including:

Razorfish Health
Biolumina
Havas Life
GSW Worldwide
Euro RSCG Life

These roles have contributed to her comprehensive understanding of account management and marketing strategies in the healthcare sector.

Education

Amy's educational background includes:

Master's degree in Communications from La Salle University
Studies at DeSales University

This academic foundation has undoubtedly supported her success in the communications and marketing field.

Location and Networking

Based in New York, New York, United States, Amy has established a strong professional network, with over 500 connections on LinkedIn.1 This extensive network likely contributes to her effectiveness in her global marketing role at Bristol Myers Squibb.

Amy O'Shaughnessy's career trajectory demonstrates her expertise in pharmaceutical marketing, particularly in the areas of digital strategy, professional marketing, and now, neuroscience. Her role as Director of Worldwide Commercial Marketing for Neuroscience at Bristol Myers Squibb positions her as a key player in the company's global marketing efforts for neurological treatments and therapies.